Skip to main content
Learn More About Proton Therapy
Learn More About Proton Therapy
 

Leadership Team

We have a world-class team of industry veterans and seasoned executives, all of whom share a common vision of delivering on the therapeutic promise of proton therapy for patients worldwide.

LEADERSHIP Team

  • Lawrence Yuan Tian, Ph.D.

    Chairman

    Lawrence Yuan Tian, Ph.D.

    Chairman

    Mevion has benefited from Dr. Lawrence Tian’s leadership as a member of the board of directors since 2015 and was appointed Chairman in 2018. Dr. Tian brings a wealth of experience from the life sciences and medical device industry to this role. He is a Founding Partner of YuanMing Capital, a leading private equity firm which focuses on the investment in pharmaceutical research and development, innovative medical devices and high-end medical services in both China and the United States. He also serves as the Chairman of Investment Committee of China Pharmaceutical Industry Research and Development Association, and he is a member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong Limited.

    Dr. Tian also brings experience networking business leaders to the Mevion leadership team. He is the founder and Chairman of the China Entrepreneurs Forum, the most influential business owners association in China, and is the founder of the China-U.S. Business Leaders Roundtable, a prestigious cross-border communication platform.

    Prior to Mevion, Dr. Tian has had successful career as a serial entrepreneur with a strong track record of success. In the financial markets, he founded China International Futures Co., Ltd. (CIFCO) in 1992. CIFCO grew into a leading brokerage firm and achieved the largest market share in China during his chairmanship. He also co-founded Wumart Group in 1994, which is currently the largest supermarket chain in Northern China.

    Dr. Tian obtained his master’s degree and doctoral degree from Wuhan University. He received the China Economics Theory Innovation Award, China’s highest prize for economics. 

  • Joseph K. Jachinowski

    Executive Director

    Joseph K. Jachinowski

    Executive Director

    With more than thirty years of experience in the field of oncology, Joe brings an unmatched depth of expertise and experience to our company. He served as Mevion’s chief executive officer and president from 2009 to 2018. Since joining the company, Joe oversaw the development of industry-leading technologies and our growth into a leading global provider of proton therapy systems.

    Joe cofounded IMPAC Medical Systems and served as its president and chief executive officer from 1990 through the company’s initial public offering and sale to Elekta in 2005. After the sale, Joe was an executive vice president of Elekta for four years running global R&D and North American commercial operations. Joe began his career at Varian Medical Systems, Inc., where he led the team that developed linear accelerators from 1983 to 1990.

    He holds a Bachelor of Science from Ohio University and Master of Science from Washington State University.

  • Tina Tianning Yu, Ph.D.

    Chief Executive Officer

    Tina Tianning Yu, Ph.D.

    Chief Executive Officer

    Mevion’s Chief Executive Officer, Dr. Tina Yu, brings more than fifteen years of professional experience working in the life sciences sector and the financing world of the healthcare industry. As a Managing Partner of YuanMing Capital, a healthcare fund focusing on cross-border investment strategies, Dr. Yu led the investment in BeiGene, Ascentage Pharmaceuticals, and Mevion Medical Systems. Prior to that, Dr. Yu worked for Vision Capital, a NYC-based investment management firm, as a Director of Investment, responsible for US biotech and China sectors. Before becoming an investor, Dr. Yu was a senior research scientist at Wyeth BioPharma, where she specialized in therapeutic protein development. She also worked for Fidelity, Morgan Stanley and Genzyme. Dr. Yu founded Matching Capital Partners to provide cross-border consulting services in the life sciences industry.

    Dr. Yu holds a PhD in Chemistry from Princeton University, an MBA from Harvard Business School, and a B.S. in Biology from University of Science and Technology of China.

  • James Meng, Ph.D.

    President

    James Meng, Ph.D.

    President

    James Meng brings in 22 years of healthcare industry experience to Mevion. Dr. Meng’s professional and executive experiences include the management positions with Siemens Healthineers, Philips Healthcare and GE Healthcare. In these roles, he had the responsibilities for developing emerging medical technologies, creating the luminary segment, achieving market leadership position and exceeding the sales target. Most recently, James was the Chief Marketing Officer and the President of Alltech Medical Systems, a Chinese healthcare company.

    Dr. Meng holds a Ph.D. from the Nuclear Engineering Department of Massachusetts Institute of Technology, and Harvard/MIT Radiological Science and Technology Program, an MS from Nuclear Physics of University of New Hampshire and a BS from Nuclear Physics from University of Science and Technology of China.

  • Stanley “Skip” Rosenthal, Ph.D.

    Vice President of Clinical Systems

    Stanley “Skip” Rosenthal, Ph.D.

    Vice President of Clinical Systems

    Skip’s twenty-five years of experience in radiation oncology and proton therapy date back to the Harvard Cyclotron Laboratory, where he optimized treatment planning and patient positioning for particle therapy. At Mevion, he leads our team in designing a practical clinical workflow, and is responsible for creating and overseeing Mevion’s customer education and training curriculum. Skip was previously a senior medical physicist at The Northeast Proton Therapy Center at Massachusetts General Hospital. He also held an assistant professorship at Harvard Medical School.

    Skip is board certified in therapeutic radiologic physics and holds a Ph.D. in physics from Brandeis University.

  • Yoel Bakas

    Senior Vice President Sales, The Americas and EMEA

    Yoel Bakas

    Senior Vice President Sales, The Americas and EMEA

    Yoel Bakas’ focus at Mevion is on increasing value for our customers. Yoel was previously a senior director of strategic accounts for Varian Medical Systems, where he developed global sales strategies and managed key accounts responsible for 10% of company revenues. He also managed Varian's Georgia and South Carolina sales district, with more than 150 healthcare accounts, and was an international sales manager for image-guided and stereotactic sales. Prior to Varian, Yoel worked for ZMED, where he successfully took the company's new ultrasound imaging technology to the global marketplace. He has 15 years of sales leadership experience and won the prestigious Certified Strategic Account Manager accreditation in 2015.
    Yoel received a Bachelor of Arts in computer science from the University of Rochester.

  • Mark Jones

    Vice President of Engineering

    Mark Jones

    Vice President of Engineering

    Mark Jones, Vice President of Engineering

    Mark joined Mevion in 2006, bringing a wide range of engineering expertise. Today, he serves as lead mechanical engineer of our magnet and RF accelerator systems. During his nearly 30 years in the industry, Mark led the development of many successful medical devices and earned five patents while developing MRI and CT imaging products at Analogic Corporation, cardiac imaging products at XRE Corporation, and most recently, genetic research and molecular diagnostics products at Affymetrix.

    Mark holds a Bachelor of Arts in mechanical engineering from Norwich University and a Master of Science in engineering management from the Gordon Institute of Tufts University.

  • Curt Kienast

    Vice President of Global Operations and Service

    Curt Kienast

    Vice President of Global Operations and Service

    Curt is an experienced executive who has been a part of our team since 2007. He previously worked in the defense industry and later joined the healthcare field as the president of Healthcare Technology Consulting, which focuses on quality and regulatory consulting. After participating in several mergers and acquisitions in the consulting industry, Curt joined us as our director of software quality. Through his ten years with us, Curt has taken on leadership positions in quality, engineering and service, and now serves as the vice president of global services.
    Curt holds a Bachelor of Science in computer engineering from Embry-Riddle Aeronautical University.

  • Thomas Faris, Esq.

    Vice President of Regulatory Affairs and Quality Assurance and Administration

    Thomas Faris, Esq.

    Vice President of Regulatory Affairs and Quality Assurance and Administration

    Thomas Faris, Esq., Vice President of Regulatory Affairs and Quality Assurance and Administration

    Thomas is a seasoned executive in regulatory affairs, quality assurance, health information privacy and security, and operational management. He has been a part of the Mevion team since 2010, having held multiple regulatory affairs and quality assurance positions at Elekta. Prior to Elekta, Thomas led the regulatory and quality functions of IMPAC Medical Systems, Inc. and Image Enhancement Systems, Inc.

    He holds a Bachelor of Science in Justice Studies from Arizona State University, a Master of Science in quality assurance from California State University Dominguez Hills, and a Juris Doctor from Golden Gate University School of Law.

  • Michael Tajima

    Senior Director of Marketing

    Michael Tajima

    Senior Director of Marketing

    Michael brings a breadth of experience in product research and positioning in critical care medical device markets to Mevion. Prior to joining Mevion, Michael led product management and product marketing efforts for cardiac and surgical medical device companies including Abiomed, HeartWare, and OmniGuide. Before medical devices, he designed optical satellite payloads for L-3 Communications.

    Michael holds a Master of Science in Mechanical Engineering from the Massachusetts Institute of Technology, and an MBA from MIT’s Sloan School of Management and a Bachelor of Science in Mechanical Engineering from Cornell University.

  • Sherri Hodgson

    Senior Director Human Resources

    Sherri Hodgson

    Senior Director Human Resources

    Sherri joined Mevion in 2017, with a broad breadth of global human resources experience. She has over 30 years of HR experience working as a strategic business partner and leader with expertise in talent management/development, employee engagement, total rewards/ recognition, program development, operational planning, and process improvement. Sherri’s experience spans multiple industries including, electronics, consumer electronics, food, and medical devices.

    Sherri holds a Bachelor of Science in Management from Lesley University.

ADVISORY COMMITTEE

Mr. Robert Wilson

Former Vice Chairman of Johnson & Johnson, Inc.

Mr. Paul Volcker
Former Chairman, United States Federal Reserve